Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Boulevard, Vine Street hop to ‘inspire our city’ with a brew in honor of KC baseball icon Buck O’Neil
A new ale crafted in collaboration between one of Kansas City’s biggest brands and the city’s first Black-owned brewery is expected to commemorate “a true American treasure,” said Kemet Coleman — as well as send 100 percent of its proceeds to the Negro Leagues Baseball Museum. The Buck O’Neil Barrel-Aged Saison honors the late first…
Mid x Midwest aims to connect 50 VCs with 50 startups; why this new meetup is coming to KC
Traveling throughout the U.S. for business, Dan Kerr regularly comes across investors who have heard rumblings about the burgeoning Kansas City tech startup ecosystem, he said. But one problem persists: most of these potential funders have never stepped foot in Kansas City. “Really what got my gears turning is that I have a big network…
Just funded: Big ‘Pure Pitch’ winners swim with the sharks, earn thousands in cash on the spot
A winning afternoon at the Pure Pitch Rally is validation Dr. Brandy Archie’s healthtech accessibility app is providing connections people actually need, she said. “That’s the most important thing to me,” said Archie, founder of AskSAMIE. “The funds are going to a good cause, but this lets me know that this new idea that I…
They met in Hollywood, but this startup found its ‘fertile field’ of dreams (and community) in Kansas
Startland News’ Startup Road Trip series explores innovative and uncommon ideas finding success in rural America and Midwestern startup hubs outside the Kansas City metro. This series is possible thanks to the Ewing Marion Kauffman Foundation, which leads a collaborative, nationwide effort to identify and remove large and small barriers to new business creation. WICHITA,…